Cerebrolysin is a neuropeptide preparation described as mimicking the action of endogenous neurotrophic factors on brain protection and repair; it is a preparation, not a single molecule.
emerging — human data exists, and it is thin or contested
every claim resolves to its source
All 3 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
created page created as 'Cerebrolysin' with aliases FPF-1070, N-PEP-12, Porcine brain peptide preparation · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
identity withheld identity not published: PubChem gave no record that proves it is this substance · 2026-09-27 04:00 · somebody
fact added summary: Cerebrolysin is a neuropeptide preparation described as mimicking the action of endogenous neurotrophic factors on brain · 2026-09-27 04:00 · somebody
fact added mechanism: In dementia models it decreased beta-amyloid deposition and tau phosphorylation and increased synaptic density; in strok · 2026-09-27 04:00 · somebody
fact added history: A 2018 meta-analysis of nine randomized ischemic-stroke trials (1,879 patients) reported greater early neurological impr · 2026-09-27 04:00 · somebody
fact added history: In the CARS trial, 21 days of Cerebrolysin alongside rehabilitation, started 24 to 72 hours after stroke, improved arm m · 2026-09-27 04:00 · somebody
citation added pmid 22514792 cited as preclinical: Review of neurotrophic pharmacology in dementia and stroke models · 2026-09-27 04:00 · somebody
citation added pmid 29248999 cited as emerging: Meta-analysis of nine randomized trials in early post-stroke recovery · 2026-09-27 04:00 · somebody
citation added pmid 26564102 cited as emerging: CARS randomized placebo-controlled trial of motor recovery after stroke · 2026-09-27 04:00 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.